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Assays for the production of leukocyte migration in-
hibition factor (LMIF) activity by cultured lymphocytes 
in the presence of the T-cell mitogen concanavalin A 
(ConA) have been shown to be highly sensitive for de-
tecting decreases in cell-mediated immunity in patients 
with malignant diseases and primary and secondary 
iInmunodeficiency diseases. We have applied the leuko-
cyte migration inhibition test in agarose using superna-
tants from ConA-stimulated lymphocyte cultures (indi-
rect leukocyte migration inhibition test in agarose for 
studying patients with atopic dermatitis . Only 5 of 14 
lymphocyte cultures from atopic dermatitis patients pro-
duced LMIF when stimulated with ConA, as compared 
with 34 of 34 controls. This difference is highly signifi-
cant. 
Immunologic studies of atopic dermatitis have been confined 
mainly to humoral immunity. With the recent increase in 
knowledge concerning the role of thymus-derived (T) cells in 
relation to bone marrow-derived (B) cell function, however, and 
more recently t he role of suppressor T cells in IgE a ntibody 
regulation [1-5] , the functions of T cells in atopic dermatitis 
have begun to be studied. 
Several authors have reported a tendency toward decreased 
delayed cutaneous hypersensitivity in patients with atopic der-
matitis [6-14], although contradictory results have also been 
reported [15,16]. Enumeration of T lymphocytes has suggested 
that the number of T cells is decreased in these patients [17-
23]. Responses of their lymphocytes to T-cell mitogens in vitro 
have also been reported to be decreased [10,18,19,22-26], but 
contradictory results concerning their responses to phytohe-
magglutinin (PHA) have been published [17,23,27-29]. 
Recent studies have shown that the assay of leukocyte 'mi-
gration inhibition factor (LMIF) activi ty produced by lympho-
cytes stimulated with the T-cell mitogen Concanavalin A 
(ConA) is a highly sensitive measure of decreased cell-mediated 
immunity in patients with Hodgkin's disease, other malignant 
lymphomas [30], and primary and secondary immunodeficiency 
diseases [31]. This assay has not been app lied previously to the 
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study of cell-mediated immunity in atopic dermatitis. In the 
present study ConA-induced release of LMIF was significantly 
decreased in patients with atopic dermatitis. 
MATERIALS AND METHODS 
Patients 
Fourteen patients with a clinical diagnosis of atopic dermatitis and 
34 age-matched healthy controls were studied. The age of the patients 
varied from 5 to 39 yr (mean 19.3 yr ). The age of 3 patients was under 
13 y r. Of the 14 patients, 2 suffered (or had previously suffered) 
symptoms of hay fever, 6 had asthma, and 4 had symptoms of both 
diseases. The mean percentage of body surface covered by atopic 
dermatitis was 30.8 (range 3-90%). The atopic dermatitis was in pro-
gression in 3 patients, static in 3 patients, and in remission in 8 patients. 
None of the patients was on steroids at the time of the st.udy or had 
taken antih istamines in 3 days before the study. 
Preparation of ConA·induced (LMIF) 
Periphera l blood leukocytes were obtained from venous blood pre-
mixed with 50 uni ts of heparin (Pan heparin, Abbot Laboratories, USA) 
per ml and 6% dextran (S igma Chemical Co., USA) in a ratio of 5 parts 
blood to 1 part dextran by sedimentation at 37°C for 30 min. Mono-
nuclear ce lls were separated on a Ficoll- lsopaque gradient by centrifu-
gation at 400 g for 40 min and washed 3 times with Du lbecco's 
phosphate-buffered saline (DPBS) (Gibco, USA) . Cells were counted 
and resuspended in HEPES-buffered T C-199 medium containing 10% 
feta l calf serum, 60 U/ml penicillin, and 60 /lg/ml streptomycin. The 
cell density was adjusted to 2 x 10'; mononuclear ce lls per ml and 
cultures of 1 ml were set up in culture tubes. Concanavalin A (Sigma) 
was used at a concentrat ion of 8 /lg/ ml which was first shown to be the 
optima l concentration for blastogenesis of lymphocytes and for re lease 
of LMIF in the cultures. The cu ltures with ConA and control cu ltures 
without ConA were centrifuged after 3 days, and the supernatants were 
co llected and tested immediately on indicator cells as described below. 
Preparation of Indicator Cell;; 
Venous blood from 14 volunteers was prepared as above. After 
centrifugation in a F icoLl -Isopaque gradient at 400 g for 40 min the 
polymorphonuclear ce lls (PMN) from the bottom of the tube were 
washed with DPBS. Red blood cells were submitted to hypotonic lysis 
for 45 sec, and the ce ll pellet was washed twice with DPBS. Polymor-
phonuclear ce lls were then resuspended in supernatants from control 
and ConA-stimulated lymphocyte cul tures. Contro l supernatants were 
used eithe r as co llected or with 8 /lg/ ml eon A added. The cell concen-
tration was adjusted to 1.5 x 10" PMN/ ml and the PMN were incubated 
with , upernatants at 37°C for 30 min before testing in the agarose 
assay. The same ba tch of indicator ce LIs in the agarose assay was used 
for testing the supernatants from one patient with atopic dermatitis 
and from 2-3 healthy controls. 
LeullOcyte Migration Inhibition T est in Agarose (LMIAT) 
The LMIA T was performed according to the procedures of Clausen 
[32,33] and Hoffman et a l [34], with modifications. Migration of the 
leukocytes was assayed in 1 % agarose (lndu biose A 37 Agaro e, 
L' lndustrie Biologique Francaise S.A.) in medium TC 199 supple-
mented with 10% horse serum (Gibco, USA), penicillin, and strepto-
myc in (Gibco, USA; 60 U and 60/lg per ml respective ly) and buffered 
with sodium bicarbonate. S ix mi.1liliters of agarose medium was poured 
into disposable 60- mm plastic Petri dishes (3002 Tissue Cu lture Dish, 
Falcon. USA) and allowed to harden. Eight to 9 wells of 2.3 mm 
diameter were punched with a stainless steel punch, and 7-/l1 samples 
of the various ce ll suspensions were placed in the wells. Each ceLl 
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eonA·induced production of leukocyte migration inhibition factor 
(LMIF) tested by indirect leukocyte migration inhibition in agarose 
(LM IAT) for 14 patients with atopic dermatitis and 34 controls. Mlgra· 
tion index (M !) was calculated as the mean area of migration in the 
presence of supernat.ants from ConA-stimulated cul tures divided by 
t he mean area of migration in the presence of supernatants from control 
cultures. 
sus pension was run in triplicate. The plates were placed in inverted 
100-mm plastic Petri dishes, which were sealed with stenle water and 
incubated for 20 hI' at 37°C in an atmosphere of 5% carbon dioxide and 
95% air. Two diameters of the migration area were measured with a 
ca librated hand ocular. Migration area was calculated from the mean 
diameter. The bottom of the well was not included in the migration 
area. The migration index was calculated by dividing the mean of the 
m igration of cells incubated with each supernatant from stimulated 
cui tu res by the mean area of the migration of cells incubated III the 
cOl'responding supernatant. from control cultures. LIF release was con-
s idered significa nt when the migration indexes were be low O.B. 
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bind sheep erythrocytes to t heir surfaces spontaneously (E 
rosettes); approximately 70% of peripheral blood lymphocytes 
do so. Gottl ieb and Hanifin [17], McGeady and Buckley [18], 
Andersen and Hjort [19], Luckasen et al [20], Carapeto, Win-
kelmann, and Jordan [21], Strannegiird, Lindholm, and Stran-
negiird [22], and Thestrup-Pedersen et al [23] have reported 
significantly lower mean percentages of T-cell rosettes in pa· 
tients with atopic dermatitis than in normals. A correlation 
between decreased number of T cells, severity of dermatitis 
[17,19,22], and serum IgE concentrations has a lso been reported 
[1 7,23]. This correlation was not found by others [18,19]. 
The P HA response in vitro has been reported by some 
authors to be depressed but not significantly decreased 
[10,18,23,24], significantly decreased [19,22,25,26], or normal 
[27- 29]. ConA-induced lymphocyte transformation has been 
reported to be decreased in patients with atopic dermatitis 
[18,22]. A correlation between decreased PHA response and 
severi ty of dermatit is was found in 3 studies [10,19,22]. No 
correlation was found by others [18,25]. A correlation between 
decreased PHA response and high IgE level was found in one 
. tudy [26]. Strannegiird , Lindholm, and Strannegiird [22] found 
a correlation between decreased ConA-induced blastogenic re-
sponse and severi ty of t he disease, and Thestrup-Pedersen et al 
[23] between decreased ConA response and high IgE level. 
McGeady and Buckley [18] did not find any correlation between 
decreased ConA-induced blastogenesis and high IgE level or 
seve ri ty of dermatitis. 
The LMIAT correlates well with skin test reactivity of de-
layed type hypersensitivity in guinea pigs [35]. Observations in 
humans have a lso shown a correlation of LMIF production wit h 
cutaneous delayed hypersensit ivity [36,37]. The 2-stage (indi-
rect) LMIAT technique has been shown to correlate even with 
the size of the skin reactions to the same ant igens [38,39]. The 
resul ts of the present study using the indirect LMIAT indicate 
that ConA-induced release of LMIF was significantly decreased 
in atopic dermatitis. N o correlation was found between de-
creased release of LMIF a nd severi ty or stage of the atopic 
dermatitis. The high sensitivity of this test for studying cellular 
immunity in immunodeficiency disease has been noted previ-
ously by Gorski et aI, who studied cell-mediated immunity in 
RESU L T S Hodgkin's disease and other malignant lymphomas [30] and in 
primary and secondary immunodeficiency disease [31]. 
The migration indexes of PMN cells in the presence of The mecha nism of decreased cell-mediated immunity in 
su pernatants from control cul tures with and without ConA many secondary immunodeficiency diseases is unknown. It has 
add ed did not differ. " been speculated that t he increased amount of one specific 
Results of ConA-induced LMIF release in 14 patients with antigen could cause the maximal response of lymphocytes of 
atopic dermatit is and in 34 healthy controls a re shown in the the host to the ant igen , and thus could cause decreases in cell-
F ig. A migration index of < 0.80 (inhibition >20%). is usuall.y mediated immunity to other a ntigens [40). It has been shown 
co nsidered to demonstrate in vitro LMIF productIOn 111 thIS that preexposure of mul t ispecific sensitized cells to antigen with 
assay. In on ly 5 of 14 patients with atopic dermatit is ConA- one specificity rendered t he cell population incapable of releas-
induced LMIF release was observed, as compared wi th 34 of 34 ing migration inhibit ion factor (MIF) to ant igens with other 
controls. This di ffe rence was highly significant (p < 0.001 by t- specificities [41]. Thus, decreased ConA-induced production of 
test) . The mean migration index was 0.79 ± 0.18 (mean ± SD) LMIF could be expla ined by in vivo release of LMIF from 
in atopic patients and 0.51 ± 0.17 in cont rols . This difference lymphocytes by some unknown antigens in atopic patients. In 
was a lso highly significant (p < 0.001 by Student's t-test) . There sarcoidosis increased amount of "spontaneous" MIF has been 
was no correlation between decreased ConA-induced release of reported [42]. Whether decreased ConA-induced release of . 
LMIF and severity or stage of atopic dermatit is. LMIF in atopic patients is due to a defect of lymphocytes to 
DISCUSSION 
eve ral authors have reported that pa tients with atopic der-
matitis demonstrate a tendency toward decreased cuta neous 
d e layed hypersensit ivi ty to tuberculin [6-9], to other bacterial, 
funga l, and vira l antigens [8-11,18], and to environmental con-
tactants [12-14]. Sensitization with rhus antigen [14] and dini-
trochlol'obenzene (DNCB) [7,10] has also been less successful 
in patients wi t h atopic dermatit is t han in controls . On the other 
hand, a number of studies have shown normal responses in skin 
tests of these patients [1 5,1 6). 
Studies of enumeration of T lymphocytes suggest decreased 
number of T cells in patients wi th atopic dermatitis. T and B 
cells can be ident ified by differences in their cell surface prop-
erties. T cells currently a re ident ified best by their ability to 
respond to ConA or due to re lease of LMIF in vivo during pre-
exposure of lymphocytes to some other stimulus will be a topic 
of fur ther studies. The reproducibility of the indirect LMIAT 
and its high sensit ivi ty as an in vitro correlate of delayed 
hyperse nsit ivity makes t his test a useful parameter for t hese 
studies in atopic dermatit is. 
We thank Charles L. Smith fo r editorial suggestions. 
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Announcement 
The fourth annual "Advanced Institute in Methods of Immunological Diagnosis," conducted under the auspices of the World 
Health Organization Collaborating Laboratory for the Serology of Autoimmune Diseases at Wayne State University School of 
Medicine, will be held June 17-23, 1979. The course is to be held on the wooded campus of Cranbrook Educational Community 
in Bloomfield Hills, Michigan. This year, the course will emphasize selected, newer methods applicable to the diagnosis of human 
diseases. 
Category 1 credit for postgraduate medical education has been approved. Deadline for receiving applications is April 15. Further 
information can be obtained by writing to: Noel R. Rose, M.D., Ph.D, Department of Immunology and Microbiology, Wayne 
State University School of Medicine, 540 East Canfield, Detroit, Michigan 48201. 
